Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

United States

Banner MD Anderson Cancer Center, Gilbert, Arizona

UC San Diego Moores Cancer Center, La Jolla, California

Yale University, New Haven, Connecticut

Carle at The Riverfront, Danville, Illinois

Carle Physician Group-Effingham, Effingham, Illinois

Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois

Carle BroMenn Medical Center, Normal, Illinois

Carle Cancer Institute Normal, Normal, Illinois

Carle Cancer Center, Urbana, Illinois

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth, Middletown, New Jersey

Memorial Sloan Kettering Bergen, Montvale, New Jersey

Memorial Sloan Kettering Commack, Commack, New York

Memorial Sloan Kettering Westchester, Harrison, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Memorial Sloan Kettering Nassau, Uniondale, New York

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio

University of Cincinnati Cancer Center-West Chester, West Chester, Ohio

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania